Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT.
Launched by FEDERAL UNIVERSITY OF SÃO PAULO · Jul 21, 2017
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
Rotational knee stability is a topic with great interest among Anterior Cruciate Ligament (ACL) Reconstruction experts. Previous papers have questioned whether current ACL reconstruction techniques may provide adequate rotational stability in all ACL-deficient individuals, considering their broad spectrum of clinical presentations (Logan 2004, Ristanis 2005). Persistent rotational instability after standard ACL reconstruction have been extensively described, and it has been shown to keep straight correlation with worse outcomes post-operatively (Chouliaras 2007, Kocher 2004). Besides, lack ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Grade 2 or 3 pivot shift test
- • Chronic ACL lesions (\>or= 1 year after lesion)
- Exclusion Criteria:
- • Previous knee surgeries
- • Chondral grade IV knee lesions
- • Concomitant knee ligament injuries, other than ACL and ALL ligaments
- • Knee osteoarthritis
- • Semitendinosus graft length shorter than 24mm.
About Federal University Of São Paulo
The Federal University of São Paulo (Universidade Federal de São Paulo - UNIFESP) is a prestigious institution dedicated to advancing education, research, and healthcare in Brazil. Renowned for its commitment to innovation and excellence, UNIFESP plays a pivotal role in clinical research, focusing on a multidisciplinary approach to improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that clinical trials conducted under its auspices adhere to rigorous ethical standards and contribute valuable insights to the medical field. With a rich history of academic achievement and a strong emphasis on translational research, UNIFESP is a key player in the development of new therapies and medical interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Patients applied
Trial Officials
Fernando C Rezende, MD
Principal Investigator
research assistant
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials